NCT02774837 Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B Status UNKNOWN Phase PHASE4
NCT02745704 The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg Status UNKNOWN Phase PHASE4
NCT02738554 Off Treatment Durability in Chronic Hepatitis B With Good Immune Control Status COMPLETED Phase NA
NCT02615639 A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB Status UNKNOWN Phase PHASE1/PHASE2
NCT02594293 Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy Status COMPLETED Phase PHASE4
NCT02589652 Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy Status UNKNOWN Phase N/A
NCT02589457 Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet Status COMPLETED Phase PHASE1
NCT02579382 Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated Status COMPLETED Phase PHASE2
NCT02569372 A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients Status COMPLETED Phase PHASE1
NCT02566148 Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France Status COMPLETED Phase N/A
NCT02565719 REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection Status COMPLETED Phase PHASE2
NCT02560649 An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients Status UNKNOWN Phase PHASE4
NCT02533544 Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B Status COMPLETED Phase N/A
NCT02532413 Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B Status UNKNOWN Phase PHASE4
NCT02523547 Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude Status UNKNOWN Phase PHASE4
NCT02505009 Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy Status COMPLETED Phase PHASE4
NCT02476695 FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis Status COMPLETED Phase N/A
NCT02474316 Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients Status UNKNOWN Phase PHASE4
NCT02463019 Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B Status UNKNOWN Phase PHASE4
NCT02452528 Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus Status TERMINATED Phase PHASE2